Vitamin D Therapy Market Size Worth $8.07 Billion By 2032 | CAGR: 11.7%

The global vitamin D therapy market size is expected to reach USD 8.07 billion by 2032, according to a new study by Polaris Market Research. The report “Vitamin D Therapy Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral); By Age Group; By Purchase Pattern; By Application; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

According to the World Health Organization (WHO), an estimated 1 Bn people across the globe have vitamin D insufficiency or deficiency. This indicates a large and growing market for vitamin D therapies. Several studies conducted across India in various regions have revealed a widespread incidence of vitamin D insufficiency in people of all ages. According to estimates, the prevalence of Vit-D deficiency ranges from 62.7% in newborns and breast-feeding populations (0-6 months) to 46.8% in children aged 6 to 60 months and from 37.8 to 97.5% in kids aged 5 to 20. According to a comprehensive review, between 37.8 and 97.5% of children aged 5 to 20 have vitamin D deficiency. This will create a wide range of opportunities for the growth of the market.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/vitamin-d-therapy-market/request-for-sample

Many people around the world are adopting lifestyles and dietary habits that do not provide sufficient vitamin D. For example, people who live in urban areas with little exposure to sunlight or those who follow restrictive diets may be at risk of vitamin D insufficiency. This has led to increased demand for vitamin D supplements and therapies to address these deficiencies. According to the World Bank, Currently, more than 50% of the world's population resides in cities. The number of people living in urban areas will more than double to 6 billion by 2045. This will further fuel the growth and demand for the market.

Vitamin D Therapy Market Report Highlights

• Oral segment is anticipated to witness higher growth due to its advantages such as convenience, effectiveness, versatility, availability, and cost-effectiveness
• Senior Adults segment accounted for the higher growth rate owing to the increased risk of deficiency, the growing aging population, and the higher incidence of chronic diseases.
• Prescription Drugs segment is expected to have a higher growth due to patient preference for prescription drugs, patent protection, and healthcare provider prescribing habits.
• Osteoporosis segment is projected to experience a significant growth rate due to the increasing prevalence of osteoporosis worldwide and growing awareness of the importance of vitamin D in maintaining bone health.
• Asia Pacific is expected to grow at a significant growth rate owing to the high incidence of vitamin D deficiency, government initiatives and lifestyle.
• The global players include GSK, Pfizer, Abbott, Sanofi, Merck, Torrent Pharmaceuticals, Novartis International, Alkem Laboratories, Sun Pharmaceutical Industries  and Cadila Healthcare.

Polaris Market Research has segmented the Vitamin D Therapy market report based on route of administration, age group, purchase pattern, application and region:

Vitamin D Therapy, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

• Oral Route
• Parenteral Route

Vitamin D Therapy, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

• Children
• Adults
• Senior Adults

Vitamin D Therapy, Purchase Pattern Outlook (Revenue - USD Billion, 2019 - 2032)

• OTC Drugs
• Prescription Drugs

Vitamin D Therapy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Osteoporosis
• Rickets
• Skin Diseases
• Muscle Weakness
• Autoimmune Disorders

Vitamin D Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa